Fingerprint
Dive into the research topics of 'Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically